Search results for "uva"

showing 10 items of 2916 documents

TUR and Adjuvant Intravesical Chemotherapy in T1G3 Bladder Tumors: Recurrence, Progression and Survival in 137 Selected Patients Followed Up to 20 Ye…

2003

Abstract OBJECTIVES: To evaluate a highly selected population of patients affected by T1G3 bladder transitional cell carcinoma (TCCB) treated by transurethral resection (TUR) and adjuvant intravesical chemotherapy. MATERIALS AND METHODS: Between January 1976 and April 1999, 137 patients with T1G3 TCCB were treated by TUR plus intravesical chemotherapy. Particularly, a sequential combination of mitomycin C (MMC) and epirubicin (EPI) was adopted in 91 patients (66.4%). The main exclusion criteria were concomitant or previous Tis, previous T1G3 TCCB, tumor size greater than 3 centimeters and number of tumors more than 3. TUR was repeated if a superficial tumor recurred. Patients went off study…

Adultmedicine.medical_specialtyTime FactorsUrologyPopulationUrologyIntravesical adjuvant chemotherapyDisease-Free SurvivalSettore MED/24 - UrologiaT1G3 bladder cancermedicineAdjuvant therapyHumanseducationSurvival rateAgedNeoplasm StagingAged 80 and overCarcinoma Transitional Celleducation.field_of_studyUrinary bladderBladder cancerbusiness.industryMiddle Agedmedicine.diseaseSurgerySurvival Ratemedicine.anatomical_structureUrinary Bladder NeoplasmsChemotherapy AdjuvantTumor progressionConcomitantDisease ProgressionUrologic Surgical ProceduresNeoplasm Recurrence LocalbusinessConservative treatmentFollow-Up StudiesEpirubicinmedicine.drugEuropean Urology
researchProduct

Modulation of oestrogen excretion profiles by adjuvant chemotherapy in pre- and postmenopausal breast cancer.

1985

Modulation of steroid status by conventional chemotherapy was studied in 31 breast cancer patients receiving CMF and in 31 age-matched breast cancer patients without any therapy, taken as controls. This was achieved through the study of oestrogen excretion profiles using previously identified parameters and referring not only to classical but also to the “other”, namely catechol and unusual, oestrogen metabolites. After CMF treatment the premenopausal patients exhibit a modified excretion pattern, mainly concerning a marked and significant reduction of classical oestrogens, as shown by pattern indices. Because there is evidence that oestriol metabolism is not markedly affected by CMF treatm…

Adultmedicine.medical_specialtyTime FactorschlormethineAdjuvant chemotherapymedicine.medical_treatmentBreast NeoplasmsBiochemistryestriolGas Chromatography-Mass SpectrometrySteroidExcretionEndocrinologyBreast cancerInternal medicineestradiolAntineoplastic Combined Chemotherapy ProtocolsmedicineestrogenHumansStage (cooking)CyclophosphamideChromatography High Pressure LiquidAgedbusiness.industryEstrogensMetabolismMiddle Agedmedicine.diseaseestroneEstrogens CatecholEndocrinologyMethotrexateMetabolic rateAdrenal CortexFemaleFluorouracilMenopausebusinessAfter treatmentJournal of steroid biochemistry
researchProduct

Long-Term Results of Ileocecal Continent Urinary Diversion in Patients Treated With and Without Previous Pelvic Irradiation

2002

Patients who receive pelvic irradiation may require urinary diversion to manage complications resulting from progressive malignancy or radiotherapy. The choice of urinary diversion is an important issue and remains controversial. We characterized the long-term outcome of urinary diversion with a continent ileocecal reservoir in patients who received pelvic irradiation versus those who underwent urinary diversion without previous irradiation.Continent urinary diversion with an ileocecal reservoir (Mainz pouch 1) was performed in 36 irradiated patients in a 9-year period. Morbidity, mortality, the reoperative rate and parameters associated with the surgical procedure were determined at a medi…

Adultmedicine.medical_specialtyUrinary systemmedicine.medical_treatmentUrologyPelvisCystectomyPostoperative ComplicationsRisk FactorsmedicineHumansDerivationRadiation InjuriesAgedUrinary bladderbusiness.industryUrinary diversionUrinary Reservoirs Continentrespiratory systemMiddle AgedCombined Modality TherapySurgerymedicine.anatomical_structureUrinary Bladder NeoplasmsFemaleRadiotherapy AdjuvantPouchbusinessComplicationhuman activitiesContinent Urinary DiversionFollow-Up StudiesThe Journal of Urology
researchProduct

Mitomycin C from birth to adulthood.

2016

Mitomycin C (MMC) intravesical therapy for “superficial” papillary bladder tumors was firstly introduced in the early seventies with promising results. In the following years, several pharmacokinetic studies investigated its mechanism of action to optimize the intravesical administration. Numerous studies confirmed thereafter both the ablative and the prophylactic efficacy and the low toxicity of MMC when intravesically given. In 1984, a complete response rate of 42% in 60 patients not responsive to thiotepa was reported with intravesical MMC at the dose of 40 mg diluted in 40 ml for 8 weeks. In the following decades, many large randomized studies showed the benefit of intravesical prophyla…

Adultmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentMitomycinAntibiotics030232 urology & nephrologyUrologyThioTEPASettore MED/24 - Urologia03 medical and health sciencesYoung Adult0302 clinical medicinePharmacokineticsMedicineHumansYoung adultChildComplete responseAntibiotics Antineoplasticbusiness.industryMedicine (all)digestive oral and skin physiologyMitomycin CGeneral MedicineRegimenUrinary Bladder Neoplasms030220 oncology & carcinogenesisUrinary Bladder NeoplasmbusinessAdjuvantHumanmedicine.drugUrologia
researchProduct

The Potential Role of Lung Ultrasound B-Lines for Detection of Lung Radio-Induced Toxicity in Breast Cancer Patients after Radiation Therapy.

2016

Breast cancer patients exposed to doses of radiation after radiotherapy could develop toxicity to lung. Lung ultrasound (LUS) is able to detect interstitial lung disease by the evaluation of B-lines. The aim of our study was to assess the number of B-lines to diagnose lung involvement after chest radiotherapy.We measured LUS B-lines in the treated and contralateral lung of 20 breast cancer patients, 1-3 months after the end of radiotherapy and 1 year after previous LUS. The sum of the B-lines number in the 72 sites on anterior and posterior chest yielded a global B-lines score.B-lines were more numerous in treated (median: 21; 1st-3rd quartiles: 11-31) versus untreated hemithorax (median: 3…

Adultmedicine.medical_specialtymedicine.medical_treatmentBreast Neoplasms030204 cardiovascular system & hematologySensitivity and Specificity03 medical and health sciences0302 clinical medicineBreast cancermedicineHumansRadiology Nuclear Medicine and imagingStage (cooking)Subclinical infectionUltrasonographyLungbusiness.industryInterstitial lung diseaseReproducibility of ResultsMiddle Agedmedicine.diseaseRadiation therapyRadiation Pneumonitismedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesisToxicityBiomarker (medicine)Feasibility StudiesFemaleRadiotherapy AdjuvantRadiologyRadiotherapy ConformalCardiology and Cardiovascular MedicinebusinessEchocardiography (Mount Kisco, N.Y.)
researchProduct

Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patient…

2016

In the treatment of breast cancer, decisions on adjuvant treatment reflect individual patient characteristics like age and comorbidity. This study assessed the association between adherence to guidelines for adjuvant treatment and survival while taking into account age at diagnosis and comorbidities. We collected the Charlson comorbidity index at baseline for 2179 women treated for primary breast cancer from 1992 to 2008 who participated in a German retrospective multicenter cohort study. We assessed subsequent adjuvant therapy guideline adherence and survival in relation to baseline comorbidities. Guidelines for adjuvant chemotherapy and radiotherapy were more often violated in patients wi…

Adultmedicine.medical_specialtymedicine.medical_treatmentBreast NeoplasmsComorbidityKaplan-Meier EstimateDisease-Free Survival03 medical and health sciences0302 clinical medicineBreast cancerInternal medicineOutcome Assessment Health CareInternal MedicinemedicineAdjuvant therapyHumans030212 general & internal medicineAgedProportional Hazards ModelsRetrospective StudiesAged 80 and overbusiness.industryHazard ratioAge FactorsRetrospective cohort studyGuidelineMiddle Agedmedicine.diseaseComorbiditySurgerySurvival RateOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisSurgeryFemaleGuideline AdherencebusinessMastectomyCohort studyFollow-Up StudiesThe breast journal
researchProduct

Minilaparoscopic aortic lymphadenectomy.

2015

Abstract Study Objective To show the feasibility of performing aortic lymphadenectomy with 3-mm instruments in gynecologic malignancies. Patient A 43-year-old, multiparous patient with serous ovarian cancer grading 2, Federation Internationale de Gynecologie et d'Obstetrique stage IC (intraoperative spillage). Intervention The patient was accidentally diagnosed with ovarian cancer after a right adnexectomy performed for an ovarian cyst. Once referred to our center, a delayed surgical staging was planned including total hysterectomy, left adnexectomy, aortic and pelvic lymphadenectomy, peritoneal biopsies, and total omentectomy. Minilaparoscopy was believed to be feasible to achieve it. Meas…

Adultmedicine.medical_specialtymedicine.medical_treatmentOperative TimeSerous ovarian cancermedicineHumansGynecologic cancerGrading (tumors)AortaOvarian NeoplasmsHysterectomyOvarian cystbusiness.industryOvarian NeoplasmMedicine (all)Lymph NodeObstetrics and GynecologyPostoperative complicationmedicine.diseaseSurgeryminilaparoscopicMinilaparoscopyFeasibility StudieSettore MED/40 - GINECOLOGIA E OSTETRICIATreatment OutcomeChemotherapy AdjuvantOperative timeFeasibility StudiesLymph Node ExcisionLymphadenectomyFemaleLaparoscopyLymph NodesNeoplasm Recurrence LocalOvarian cancerbusinessaortic lymphadenectomyHumanJournal of minimally invasive gynecology
researchProduct

How Technology Can Impact Surgeon Performance: A Randomized Trial Comparing 3-Dimensional versus 2-Dimensional Laparoscopy in Gynecology Oncology

2016

This randomized clinical trial (Canadian Task Force classification I) aimed to compare 2-dimension (2-D) versus 3-dimensional (3-D) laparoscopic hysterectomy and pelvic lymphadenectomy in endometrial and cervical cancer patients. Between December 2014 and March 2015, 90 patients were enrolled: 29 (32.2%) with early or locally advanced cervical cancer after neoadjuvant treatment and 61 (67.8%) with early-stage endometrial cancer. Patients were randomly assigned to undergo 2-D (Group A, n = 48 [53.3%]) or 3-D (Group B, n = 42 [46.7%)]) laparoscopy. Baseline characteristics were superimposable in the 2 groups. Median operative time was similar in the 2 groups. Median estimated blood loss durin…

Adultmedicine.medical_specialtymedicine.medical_treatmentOperative TimeUterine Cervical NeoplasmsHysterectomylaw.invention03 medical and health sciencesImaging Three-DimensionalPostoperative Complications0302 clinical medicineRandomized controlled trialEndometrial cancerlawThree-dimensional laparoscopicmedicineHumansLaparoscopyNeoadjuvant therapyCervical cancer; Endometrial cancer; Three-dimensional laparoscopicAgedSurgeonsGynecologyCervical cancerHysterectomymedicine.diagnostic_testbusiness.industryEndometrial cancerGeneral surgeryObstetrics and GynecologyPerioperativeMiddle Agedmedicine.diseaseNeoadjuvant TherapyEndometrial NeoplasmsSurgery030220 oncology & carcinogenesisCervical cancerLymph Node ExcisionFemaleLaparoscopy030211 gastroenterology & hepatologyLymphadenectomyClinical CompetenceCervical cancer; Endometrial cancer; Three-dimensional laparoscopic; Obstetrics and Gynecologybusiness
researchProduct

Self-Reported Restrictive Eating, Eating Disorders, Menstrual Dysfunction, and Injuries in Athletes Competing at Different Levels and Sports

2021

The purpose of this study was to investigate the prevalence of self-reported restrictive eating, current or past eating disorder, and menstrual dysfunction and their relationships with injuries. Furthermore, we aimed to compare these prevalences and associations between younger (aged 15–24) and older (aged 25–45) athletes, between elite and non-elite athletes, and between athletes competing in lean and non-lean sports. Data were collected using a web-based questionnaire. Participants were 846 female athletes representing 67 different sports. Results showed that 25%, 18%, and 32% of the athletes reported restrictive eating, eating disorders, and menstrual dysfunction, respectively. Higher ra…

Adultnaisetsports injuryAdolescentkuukautisetArticleFeeding and Eating DisordersYoung AdultRisk FactorsSurveys and QuestionnairesPrevalenceHumansTX341-641menstrual irregularityfemale athleteAmenorrheaMenstrual CycleMenstruation DisturbancesurheiluvammatNutrition. Foods and food supplyFeeding Behaviordisordered eatingMiddle AgedkuukautiskiertoCross-Sectional StudiesAthleteseating disorderAthletic InjuriesFemaleSelf ReportsyömishäiriöturheilijatSportsNutrients
researchProduct

Characterization of an epithelial, nearly diploid liver cell strain, from Chinese hamster, able to activate promutagens

1987

Epithelial liver cells of the Chinese hamster (CHEL cells) were propagated in culture for 35 passages. At favourable cell densities, the population doubling time in normal medium, was 20 h. L-Tyrosine amino transferase activity was retained at a measurable level, but its enhancement by dexamethasone was detected solely in cells of early passages. Pyruvate kinase was strongly activated by fructose-1,6-biphosphate at low substrate concentrations. These enzymatic properties suggest that the CHEL cells are derived from a sub-population of parenchymal hepatocytes or from cells closely related to parenchymal hepatocytes. With a lag period of a few hours, CHEL cultures metabolized benzo[a]pyrene. …

Aflatoxin B1910-Dimethyl-12-benzanthraceneHealth Toxicology and MutagenesisPyruvate KinaseCellToxicologyEpitheliumChinese hamsterCricetulusAflatoxinsCricetinaeBenzo(a)pyreneGeneticsmedicineAnimalsDoubling timeBiotransformationCells CulturedGenetics (clinical)Tyrosine TransaminaseGeneticsbiologyLiver cellEpithelial CellsMonooxygenasebiology.organism_classificationMolecular biologyClone CellsEpoxide hydrolase activitymedicine.anatomical_structureLiverKaryotypingPloidyCell DivisionPyruvate kinaseMutagensMutagenesis
researchProduct